Association study of G1704T and G82S polymorphisms of RAGE gene for microalbuminuria in Japanese type 2 diabetic patients

Metabolism: Clinical and Experimental

Volumn 54, Issue 4, 2005, Pages 488-491

  Yoshioka, Keiji ^a   Yoshida, Toshihide ^b,c   Takakura, Yasuto ^b   Umekawa, Tsunekazu ^b   Kogure, Akinori ^b   Toda, Hitoshi ^d   Yoshikawa, Toshikazu ^e  

^a MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KYOTO CITY HOSPITAL   (Japan)

^d Sakazaki Clinic   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GENOMIC DNA; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 15744363512     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.11.001     Document Type: Article

References (25)

1. T. Nishikawa, D. Edelstein, and M. Brownlee The missing link: a single unifying mechanism for diabetic complications Kidney Int. 58 2000 S26 S30
2. D.S. Raj, D. Choudhury, and T.C. Welbourne Advanced glycation end products: a nephrologist's perspective Am. J. Kidney Dis. 35 2000 365 380
3. A.M. Schmidt, M. Hasu, and D. Popoy Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins Proc. Natl. Acad. Sci. U. S. A. 91 1994 8807 8811
4. Y. Naka, L.G. Bucciarell, and T. Wendt RAGE axis: animal models and novel insights into the vascular complications of diabetes Arterioscler. Thromb. Vasc. Biol. 24 2004 1324 1349
5. S. Sakurai, H. Yonekura, and Y. Yamamoto The AGE-RAGE system and diabetic nephropathy J. Am. Soc. Nephrol. 14 2003 S259 S263
6. A.M. Schmidt, S.D. Yan, and J.L. Wautier Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis Circ. Res. 84 1999 489 497
7. K. Kankova, A. Vasku, D. Hajek, J. Zahejsky, and V. Vasku Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes Diabetes Care 22 1999 1745b [letter]
8. G. Kumaramanickavel, V.L. Ramprasad, and S. Spripriya Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients J. Diabetes Complications 16 2002 391 394
9. B.I. Hudson, M.H. Stickland, and T.S. Fusters Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy Diabetes 50 2001 1505 1511
10. K. Konkova, M. Beranek, and D. Hajek Polymorphisms 1704G/T, 2184A/G, and 2245G/A in the rage gene are not associated with diabetic retinopathy in NIDDM: pilot study Retina 22 2002 119 121
11. X. JiXong, X. BiLin, and Y. MingGong -429T/C and -374T/A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes Diabetes Care 26 2003 2696 2697 [letter]
12. M. Globocnik Petrovic, K. Steblovnik, and B. Peterlin The -429T/C and -374T/A polymorphisms of advanced glycation end products gene are not risk factors for diabetic retinopathy in Caucasians with type 2 diabetes Klin. Monatsbl. Augennheilkd. 220 2003 873 876
13. K. Peteersson-Fernholm, C. Forsblom, and B.I. Hudson The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients Diabetes 52 2003 891 894
14. O. Poirier, V. Nicaud, and N. Vionnet Polymorphism screening of four genes encoding advanced glycation end-product putative receptors. Association study with nephropathy in type 1 diabetic patients Diabetes 50 2001 1214 1218
15. S. Matsunaga-Irie, T. Murayama, and Y. Yamamoto Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients Diabetes Care 27 2004 303 307
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 26 Suppl. 1 2003 S5 S20
17. Y. Yamada, H. Izawa, and S. Ichihara Prediction of the risk of myocardial infarction from polymorphisms in candidate genes N. Engl. J. Med. 347 2002 1916 1923
18. J.L. Wautier, C. Zoukourian, and O. Chappey Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats J. Clin. Invest. 97 1996 238 243
19. Y. Yamamoto, I. Kato, and T. Doi Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice J. Clin. Invest. 108 2001 261 268
20. M. Quinn, M.C. Angelico, and J.H. Warram Familial factors determine the development of diabetic nephropathy in patients with IDDM Diabetologia 39 1996 940 945
21. B.I. Hudson, M.H. Stickland, and P.J. Grant Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups Diabetes 47 1998 1155 1157
22. L. Liu, and K. Xiang RAGE Gly82Ser polymorphism in diabetic microangiopathy Diabetes Care 22 1999 646 [letter]
23. G.R. Isermann, T.S. Schiekofer, and M.A.J.G. Schneider A63bp deletion in the promoter of RAGE correlates with a decreased risk for nephropathy in patients with type 2 diabetes Exp. Clin. Endocrinol. Diabetes 112 2004 135 141
24. G. Prevost, I. Fajardy, and P. Fontaine Human RAGE GLY82SER dimorphism and HLA class II DRB1-DQB1 haplotypes in type 1 diabetes Eur. J. Immunogenet. 26 1999 343 348
25. M.P. Wautier, O. Chappey, and S. Corda Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE Am. J. Physiol. 280 2001 E685 E694